Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Biomarker Research

From snapshot to family tree – writing the evolutionary rule book of cancer

For hundreds of years the Scottish Highlands have resounded to the names of their famous clans: MacDonald, Campbell, Fraser, and many more. Each clan is a complex,...

Gene signature could predict breast cancer aggressiveness

Measuring the activity levels of particular genes in a woman’s breast tumour could identify more aggressive forms of the disease.

Gene linked to aggressive breast cancer

UK scientists have linked an overactive gene to an aggressive type of breast cancer.

The Enemy Within – 50 years of fighting cancer

Cancer has always been with us, affecting our species for many thousands of years. For most of that time there was little we could do in the face of such a powerful...

UK Government missing the target over new cancer drug tests

Many of the new generation of cancer drugs are designed to target specific genetic mutations in a patient’s cancer – these are often known as ‘targeted’ medicines.


Lung cancer evolution – a journey through space and time

Not so long ago, the top floor of Cancer Research UK’s London Research Institute housed a library, where the Institute’s 300-odd researchers could look back over decades...

Citizen Science: “you don’t need to be qualified to do this”

If you could recruit a helping hand for some of the more time-consuming parts of your day to day job, would you accept it?

Well, groups of our researchers are doing...

Marker found in one in six people could give higher risk of lung and other cancers

Cancer Research UK scientists have discovered why a gene fault found in around one in six people gives a higher risk of 26 cancer types.

Andrew Biankin: We need a “We can do this!” attitude to pancreatic cancer

Right now, the outlook for pancreatic cancer is bleak. Despite heartfelt efforts by researchers, survival has barely shifted over recent decades. Fewer than three in every...

Prostate cancer: researchers begin to unpick drug resistance

The recent arrival of two new drugs for advanced prostate cancer – abiraterone and enzalutamide – has offered a lifeline to men with the disease.

They both work by...